title: PTH stimulates bone formation in mice deficient in Lrp5.
abstract: Lrp5 deficiency decreases bone formation and results in low bone mass. This study evaluated the bone anabolic response to intermittent PTH treatment in Lrp5-deficient mice. Our results indicate that Lrp5 is not essential for the stimulatory effect of PTH on cancellous and cortical bone formation.
  
  
  BACKGROUND
  Low-density lipoprotein receptor-related protein 5 (Lrp5), a co-receptor in canonical Wnt signaling, increases osteoblast proliferation, differentiation, and function. The purpose of this study was to use Lrp5-deficient mice to evaluate the potential role of this gene in mediating the bone anabolic effects of PTH.
  
  
  METHODS
  Adult wildtype (WT, 23 male and 25 female) and Lrp5 knockout (KO, 27 male and 26 female) mice were treated subcutaneously with either vehicle or 80 microg/kg human PTH(1-34) on alternate days for 6 weeks. Femoral BMC and BMD were determined using DXA. Lumbar vertebrae were processed for quantitative bone histomorphometry. Bone architecture was evaluated by microCT. Data were analyzed using a multiway ANOVA.
  
  
  RESULTS
  Cancellous and cortical bone mass were decreased with Lrp5 deficiency. Compared with WT mice, cancellous bone volume in the distal femur and the lumbar vertebra in Lrp5 KO mice was 54% and 38% lower, respectively (p<0.0001), whereas femoral cortical thickness was 11% lower in the KO mice (p<0.0001). The decrease in cancellous bone volume in the lumbar vertebrae was associated with a 45% decrease in osteoblast surface (p<0.0001) and a comparable decrease in bone formation rate (p<0.0001). Osteoclast surface, an index of bone resorption, was 24% lower in Lrp5 KO compared with WT mice (p<0.007). Treatment of mice with PTH for 6 weeks resulted in a 59% increase in osteoblast surface (p<0.0001) and a 19% increase in osteoclast surface (p=0.053) in both genotypes, but did not augment cancellous bone volume in either genotype. Femur cortical thickness was 11% higher in PTH-treated mice in comparison with vehicle-treated mice (p<0.0001), regardless of genotype.
  
  
  CONCLUSIONS
  Whereas disruption of Lrp5 results in decreased bone mass because of decreased bone formation, Lrp5 does not seem to be essential for the stimulatory effects of PTH on cancellous and cortical bone formation.
authors.affiliation: Department of Physiological Sciences, University of Florida, Gainesville, USA. Urszula.Iwaniec@oregonstate.edu
authors.forename: Urszula T
authors.initials: UT
authors.lastname: Iwaniec
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Wronski
authors.forename: Jeff
authors.initials: J
authors.lastname: Liu
authors.forename: Mercedes F
authors.initials: MF
authors.lastname: Rivera
authors.forename: Rosemarie R
authors.initials: RR
authors.lastname: Arzaga
authors.forename: Gwenn
authors.initials: G
authors.lastname: Hansen
authors.forename: Robert
authors.initials: R
authors.lastname: Brommage
mesh_terms: D000818:Animals; D005260:Female; D026502:LDL-Receptor Related Proteins / Q000172:deficiency* / Q000378:metabolism; D060492:Low Density Lipoprotein Receptor-Related Protein-5; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010012:Osteogenesis / Q000502:physiology*; D010281:Parathyroid Hormone / Q000378:metabolism*
chemical_list: D026502:LDL-Receptor Related Proteins; C555482:LRP5 protein, human; D060492:Low Density Lipoprotein Receptor-Related Protein-5; C555483:Lrp5 protein, mouse; D010281:Parathyroid Hormone